487 related articles for article (PubMed ID: 30106632)
21. Prognostic implications of radioiodine avidity and serum thyroglobulin in differentiated thyroid carcinoma with distant metastasis.
Kim HJ; Lee JI; Kim NK; Min YK; Kim SW; Chung JH
World J Surg; 2013 Dec; 37(12):2845-52. PubMed ID: 24085223
[TBL] [Abstract][Full Text] [Related]
22. Role of Thyroglobulin Doubling Time in Differentiated Thyroid Cancer and Its Relationship with Demographic-Histopathologic Risk Factors and
Araz M; Soydal Ç; Özkan E; Akkuş P; Nak D; Küçük NÖ; Kır KM
Cancer Biother Radiopharm; 2021 Jun; 36(5):425-432. PubMed ID: 32379488
[No Abstract] [Full Text] [Related]
23. Estimating the Growth Rate of Lung Metastases in Differentiated Thyroid Carcinoma: Response Evaluation Criteria in Solid Tumors or Doubling Time?
Song E; Ahn J; Jeon MJ; Lee SM; Lee JH; Kim TY; Baek JH; Kim WB; Shong YK; Kim WG
Thyroid; 2020 Mar; 30(3):418-424. PubMed ID: 31880976
[No Abstract] [Full Text] [Related]
24. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): a review for clinicians.
Rosario PW; Mourão GF
Endocr Relat Cancer; 2019 May; 26(5):R259-R266. PubMed ID: 30913533
[TBL] [Abstract][Full Text] [Related]
25. Follicular Variant of Papillary Thyroid Cancer with Bilateral Renal Metastases Discovered Incidentally During Work-Up of Primary Endometrial Cancer: A Rare Occurrence.
Lubana SS; Singh N; Tuli SS; Bashir T; Sachmechi I; Kemeny MM
Am J Case Rep; 2015 Jul; 16():459-68. PubMed ID: 26181765
[TBL] [Abstract][Full Text] [Related]
26. Exploration of BRAFV600E as a diagnostic adjuvant in the non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
Johnson DN; Sadow PM
Hum Pathol; 2018 Dec; 82():32-38. PubMed ID: 30146440
[TBL] [Abstract][Full Text] [Related]
27. Factors influencing the basal and recombinant human thyrotropin-stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma.
Robbins RJ; Srivastava S; Shaha A; Ghossein R; Larson SM; Fleisher M; Tuttle RM
J Clin Endocrinol Metab; 2004 Dec; 89(12):6010-6. PubMed ID: 15579752
[TBL] [Abstract][Full Text] [Related]
28. Clinical Characteristics of Subtypes of Follicular Variant Papillary Thyroid Carcinoma.
Kim MJ; Won JK; Jung KC; Kim JH; Cho SW; Park DJ; Park YJ
Thyroid; 2018 Mar; 28(3):311-318. PubMed ID: 29343212
[TBL] [Abstract][Full Text] [Related]
29. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma.
Zhao L; Dias-Santagata D; Sadow PM; Faquin WC
Cancer Cytopathol; 2017 May; 125(5):323-331. PubMed ID: 28192645
[TBL] [Abstract][Full Text] [Related]
30. Invasion rather than nuclear features correlates with outcome in encapsulated follicular tumors: further evidence for the reclassification of the encapsulated papillary thyroid carcinoma follicular variant.
Ganly I; Wang L; Tuttle RM; Katabi N; Ceballos GA; Harach HR; Ghossein R
Hum Pathol; 2015 May; 46(5):657-64. PubMed ID: 25721865
[TBL] [Abstract][Full Text] [Related]
31. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
[No Abstract] [Full Text] [Related]
32. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases.
Lin JD; Huang MJ; Juang JH; Chao TC; Huang BY; Chen KW; Chen JY; Li KL; Chen JF; Ho YS
Thyroid; 1999 Dec; 9(12):1227-35. PubMed ID: 10646663
[TBL] [Abstract][Full Text] [Related]
33. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
[TBL] [Abstract][Full Text] [Related]
34. The follicular variant of papillary thyroid cancer and noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP).
Scharpf J; Kamani D; Sadow PM; Randolph GW
Curr Opin Oncol; 2017 Jan; 29(1):20-24. PubMed ID: 27845971
[TBL] [Abstract][Full Text] [Related]
35. Clinical Safety of Renaming Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: Is NIFTP Truly Benign?
Parente DN; Kluijfhout WP; Bongers PJ; Verzijl R; Devon KM; Rotstein LE; Goldstein DP; Asa SL; Mete O; Pasternak JD
World J Surg; 2018 Feb; 42(2):321-326. PubMed ID: 28828746
[TBL] [Abstract][Full Text] [Related]
36. Systematic Review and Meta-analysis of the Impact of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) on Cytological Diagnosis and Thyroid Cancer Prevalence.
Ruanpeng D; Cheungpasitporn W; Thongprayoon C; Hennessey JV; Shrestha RT
Endocr Pathol; 2019 Sep; 30(3):189-200. PubMed ID: 31338752
[TBL] [Abstract][Full Text] [Related]
37. Sonographic and cytologic differences of NIFTP from infiltrative or invasive encapsulated follicular variant of papillary thyroid carcinoma: A Review of 179 Cases.
Yang GCH; Fried KO; Scognamiglio T
Diagn Cytopathol; 2017 Jun; 45(6):533-541. PubMed ID: 28332339
[TBL] [Abstract][Full Text] [Related]
38. Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthle-cell neoplasms of the thyroid.
Suh I; Vriens MR; Guerrero MA; Griffin A; Shen WT; Duh QY; Clark OH; Kebebew E
Am J Surg; 2010 Jul; 200(1):41-6. PubMed ID: 20637335
[TBL] [Abstract][Full Text] [Related]
39. Preoperative Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Prospective Analysis.
Strickland KC; Vivero M; Jo VY; Lowe AC; Hollowell M; Qian X; Wieczorek TJ; French CA; Teot LA; Sadow PM; Alexander EK; Cibas ES; Barletta JA; Krane JF
Thyroid; 2016 Oct; 26(10):1466-1471. PubMed ID: 27457786
[TBL] [Abstract][Full Text] [Related]
40. Pathological evaluation of differentiated thyroid cancer in patients with positive serum thyroglobulin and negative iodine scan.
Ansari M; Babaei AA; Shafiei B; Javadi H; Assadi M; Nabipour I; Asli IN
Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1925-9. PubMed ID: 25010624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
